Literature DB >> 25445021

Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families.

Kira Bona1, Wendy B London2, Dongjing Guo3, Gregory Abel4, Leslie Lehmann2, Joanne Wolfe5.   

Abstract

Poverty is correlated with negative health outcomes in pediatric primary care and subspecialties; its association with childhood hematopoietic stem cell transplantation (HSCT) patterns of care and clinical outcomes is not known. We describe family-reported financial hardship at a primary referral center in New England and explore the relationship between measures of poverty and patterns of care and clinical outcomes. Forty-five English-speaking parents of children after allogeneic HSCT in the prior 12 months completed a 1-time survey (response rate 88%). Low-income families, defined as ≤200% federal poverty level (FPL), were compared with all others. Eighteen (40%) families reported pre-HSCT incomes ≤200% FPL. Material hardship, including food, housing, or energy insecurity was reported by 17 (38%) families in the cohort. Low-income families reported disproportionate transplantation-related income losses, with 7 (39%) reporting annual income losses of >40% compared with 2 (18%) wealthier families (P = .02). In univariate analyses, 11 (61%) low-income children experienced graft-versus-host disease (GVHD) of any grade in the first 180 days after HSCT compared with 2 (7%) wealthier children (P = .004). We conclude that low income and, in particular, material hardship, are prevalent in a New England pediatric HSCT population and represent targets for improvement in quality of life. The role of poverty in mediating GVHD deserves further investigation in larger studies that can control for known risk factors and may provide a targetable source of transplantation-associated morbidity.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Financial hardship; Graft-versus-host disease; Hematopoietic stem cell transplantation; Pediatric; Poverty

Mesh:

Year:  2014        PMID: 25445021     DOI: 10.1016/j.bbmt.2014.10.016

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  14 in total

Review 1.  Childhood to adult transition and long-term follow-up after blood and marrow transplantation.

Authors:  M C Cupit; C Duncan; B N Savani; S K Hashmi
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

2.  Trajectories of marital, parent-child, and sibling conflict during pediatric cancer treatment.

Authors:  Lynn Fainsilber Katz; Kaitlyn Fladeboe; Iris Lavi; Kevin King; Joy Kawamura; Debra Friedman; Bruce Compas; David Breiger; Liliana Lengua; Kyrill Gurtovenko; Nicole Stettler
Journal:  Health Psychol       Date:  2018-05-28       Impact factor: 4.267

3.  Feasibility of systematic poverty screening in a pediatric oncology referral center.

Authors:  Daniel J Zheng; Derek Shyr; Clement Ma; Anna C Muriel; Joanne Wolfe; Kira Bona
Journal:  Pediatr Blood Cancer       Date:  2018-08-01       Impact factor: 3.167

4.  Financial and Social Hardships in Families of Children with Medical Complexity.

Authors:  Joanna Thomson; Samir S Shah; Jeffrey M Simmons; Hadley S Sauers-Ford; Stephanie Brunswick; David Hall; Robert S Kahn; Andrew F Beck
Journal:  J Pediatr       Date:  2016-02-17       Impact factor: 4.406

5.  Rationale and design of Children's Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States.

Authors:  Melissa Beauchemin; Sheila Judge Santacroce; Kira Bona; Ha Dang; Sarah Alexander; Kamala Allen; Crystal De Los Santos; Beth Fisher; Yudy Muñeton-Castaño; Olivia Ponce; Sarah Vargas; Aaron Sugalski; Lillian Sung; Susan Parsons
Journal:  BMC Health Serv Res       Date:  2022-06-28       Impact factor: 2.908

Review 6.  Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients.

Authors:  Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 7.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.

Authors:  Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-19       Impact factor: 5.742

Review 8.  Bending the Cost Curve in Childhood Cancer.

Authors:  Heidi Russell; M Brooke Bernhardt
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

9.  Pediatric Palliative Care Parents' Distress, Financial Difficulty, and Child Symptoms.

Authors:  Jackelyn Y Boyden; Douglas L Hill; Russell T Nye; Kira Bona; Emily E Johnston; Pamela Hinds; Sarah Friebert; Tammy I Kang; Ross Hays; Matt Hall; Joanne Wolfe; Chris Feudtner
Journal:  J Pain Symptom Manage       Date:  2021-08-20       Impact factor: 3.612

10.  Associations of Age, Gender, and Family Income with Quality of Life in Children With Advanced Cancer.

Authors:  Piera C Robson; Mary S Dietrich; Terrah Foster Akard
Journal:  J Pediatr Oncol Nurs       Date:  2021-03-09       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.